Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-004129
Filing Date
2025-09-12
Accepted
2025-09-12 16:38:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12364
  Complete submission text file 0001172661-25-004129.txt   14186
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Subject) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-86112 | Film No.: 251311990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

EIN.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G